These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7680386)

  • 21. Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge.
    Hislop AD; Good MF; Mateo L; Gardner J; Gatei MH; Daniel RC; Meyers BV; Lavin MF; Suhrbier A
    Nat Med; 1998 Oct; 4(10):1193-6. PubMed ID: 9771756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant viral vaccines for enzootic bovine leucosis.
    Daniel RC; Gatei MH; Good MF; Boyle DB; Lavin MF
    Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():399-404. PubMed ID: 8270269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovine MHC class II DRB1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma.
    Nagaoka Y; Kabeya H; Onuma M; Kasai N; Okada K; Aida Y
    Cancer Res; 1999 Feb; 59(4):975-81. PubMed ID: 10029093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of ovine MHC class II DRB1 alleles on immune response in bovine leukemia virus infection.
    Konnai S; Takeshima SN; Tajima S; Yin SA; Okada K; Onuma M; Aida Y
    Microbiol Immunol; 2003; 47(3):223-32. PubMed ID: 12725293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
    Portetelle D; Dandoy C; Burny A; Zavada J; Siakkou H; Gras-Masse H; Drobecq H; Tartar A
    Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.
    Johnson RP; Trocha A; Buchanan TM; Walker BD
    J Exp Med; 1992 Apr; 175(4):961-71. PubMed ID: 1372650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiological and serological studies of bovine leukemia virus (BLV) infection in Thailand cattle.
    Lee E; Kim EJ; Ratthanophart J; Vitoonpong R; Kim BH; Cho IS; Song JY; Lee KK; Shin YK
    Infect Genet Evol; 2016 Jul; 41():245-254. PubMed ID: 27090024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
    Kundu SK; Katzenstein D; Moses LE; Merigan TC
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11204-8. PubMed ID: 1360665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 T lymphocyte activation in BLV-induced persistent B lymphocytosis in cattle.
    Stone DM; Norton LK; Chambers JC; Meek WJ
    Clin Immunol; 2000 Sep; 96(3):280-8. PubMed ID: 10964547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.
    Chentoufi AA; Zhang X; Lamberth K; Dasgupta G; Bettahi I; Nguyen A; Wu M; Zhu X; Mohebbi A; Buus S; Wechsler SL; Nesburn AB; BenMohamed L
    J Immunol; 2008 Jan; 180(1):426-37. PubMed ID: 18097044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability.
    Bruck C; Rensonnet N; Portetelle D; Cleuter Y; Mammerickx M; Burny A; Mamoun R; Guillemain B; van der Maaten MJ; Ghysdael J
    Virology; 1984 Jul; 136(1):20-31. PubMed ID: 6204449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1.
    Orlik O; Ban J; Hlavaty J; Altaner C; Kettmann R; Portetelle D; Splitter GA
    J Virol; 1997 Apr; 71(4):3263-7. PubMed ID: 9060692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T lymphocyte responses of sheep to bovine leukaemia virus infection.
    Ward WH; Dimmock CK; Eaves FW
    Immunol Cell Biol; 1992 Oct; 70 ( Pt 5)():329-36. PubMed ID: 1335963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a specific serological test and an efficient subunit vaccine to control bovine leukemia virus infection.
    Portetelle D; Burny A; Desmettre P; Mammerickx M; Paoletti E; Zavada J
    Dev Biol Stand; 1990; 72():81-90. PubMed ID: 1704325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bovine leukemia virus (BLV) envelope glycoprotein gp51 as a general model for the design of a subunit vaccine against retroviral infection: mapping of functional sites through immunological and structural data.
    Callebaut I; Mornon JP; Burny A; Portetelle D
    Leukemia; 1994 Apr; 8 Suppl 1():S218-21. PubMed ID: 7512181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of tumor necrosis factor alpha mRNA is associated with bovine-leukemia virus (BLV) elimination in the early phase of infection.
    Kabeya H; Ohashi K; Oyunbileg N; Nagaoka Y; Aida Y; Sugimoto C; Yokomizo Y; Onuma M
    Vet Immunol Immunopathol; 1999 May; 68(2-4):255-65. PubMed ID: 10438324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immunoinformatics study reveals a new BoLA-DR-restricted CD4+ T cell epitopes on the Gag protein of bovine leukemia virus.
    Pluta A; Taxis TM; van der Meer F; Shrestha S; Qualley D; Coussens P; Rola-Łuszczak M; Ryło A; Sakhawat A; Mamanova S; Kuźmak J
    Sci Rep; 2023 Dec; 13(1):22356. PubMed ID: 38102157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.